Abstract
Background and Purpose: The use of pharmacogenomic testing (PGT) can optimize medication therapy to each patient resulting in fewer adverse side effects and increased adherence. The purpose of this project was to evaluate the current use, attitudes, and practices of cytochrome p450 genetic testing followed by distribution of reference guide to assist with integration into practice.|Methods: Assessment of current provider knowledge, attitudes, and use of PGT was evaluated via a pre-intervention survey followed by an educational in-service. A post-intervention survey evaluated any change in knowledge or confidence from the pre-survey. The convenience sample for this project included two groups. The first group consisted of 19 adult patients who underwent PGT. The second group consisted of ten providers who work at the four clinics.|Conclusion: Majority of providers lacked the confidence and knowledge about PGT to fully utilize. The provider in-service brought forth an increase in the likelihood of ordering PGT, confidence in counseling patients and adjusting current medication regimens, and test awareness.|Implications for Practice: Current use of PGT is low due to lack of knowledge and confidence. Formal education about PGT is recommended to sustain PGT. Patient outcomes will directly benefit from the use of PGT.